Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.

Education

Internet

Flatiron Health

Rory Brecker serves as General Counsel at Flatiron Health, where she leads the Legal team, as well as supports strategic partnerships and M&A activity across the company.

Prior to joining Flatiron, she practiced as a corporate healthcare associate at DLA Piper. Her practice included representation of strategic buyers and sellers, equity fund sponsors, and healthcare providers in all facets of M&A, as well as on-going representation of equity fund portfolio companies, including general corporate governance and other day-to-day corporate and healthcare regulatory matters. Before DLA, Rory was the Ethics & Compliance Manager at Nicklaus Children’s Hospital, a nationally ranked pediatric hospital.

Rory earned her bachelor’s degree from University of Wisconsin-Madison and J.D. from University of Florida – Levin College of Law.

Rory Brecker

Bruce is responsible for guiding our long term growth and operating performance across Flatiron, and scaling the enterprise capabilities, systems, and processes required to achieve our ambitions.

Prior to joining Flatiron, Bruce was Chief Legal Officer at Zocdoc and EVP of Business Development and General Counsel (GC) at Oscar Health, where he was integral to scaling operations and driving growth.

Bruce graduated from Harvard Law School and received his bachelor’s degree from Harvard University in Economics.

Bruce Gottlieb

Ara Tucker

Achin is the VP of Engineering for the Evidence organization and oversees the software engineering teams that build and deliver Flatiron’s real-world evidence (RWE) and prospective (Clinical Research) products and services. In addition, Achin is a proud executive sponsor for the south asian employee resource group at Flatiron.
Prior to joining Flatiron in 2015, Achin has held various engineering roles in Siemens Medical Solutions, Goldman Sachs and Bazaarvoice.
Achin recieved a bachelor of science in computer science from the Georgia Institute of Technology.

Achin Batra

Emily Guerin is the Head of Communications at Flatiron Health, a position she has held since September of 2020. Emily joined Flatiron Health in November of 2018.

Prior to Flatiron Health, Emily was Director of Internal Communications  and Corporate Affairs at Blue Apron.  

Emily Guerin

Dana Kessler is the Customer Communications Manager at [Flatiron Health](/org/flatiron-health). Dana has previous experience working as a Marketing Manager at [Bank of America](/org/bank-of-america), [Curi](/org/curi), and Healthcare Providers Insurance Exchange. Kessler has a passion for marketing and communications and enjoys working with customers to ensure their satisfaction.

Dana Kessler has a Master of Business Administration (MBA) from [Duke University](/org/duke-university)'s Fuqua School of Business and a BBA in Finance from The George Washington University School of Business.

Some of their coworkers include Barbara Rosen - Director, Corporate Communications. Dana Kessler reports to Emily Guerin, Head of Communications.

Dana Kessler

Javier Jimenez is the current Chief Medical Officer at [Flatiron Health](/org/flatiron-health). Prior to this, they were the Executive VP RWE & Late Phase at [Syneos Health](/org/syneos-health) from February 2020 to June 2022. Before that, they were the VP Global Head RWE and Clinical Outcomes at [Sanofi](/org/sanofi) from January 2017 to January 2020. 

Previously, Javier Jimenez was the Director Global Epidemiology and Real World Evidence Design and Analytics at [AstraZeneca](/org/astrazeneca) R&D from April 2012 to August 2013. From August 2013 to December 2016, they served as the VP Medical Evidence and Observational Research at [AstraZeneca](/org/astrazeneca). And from March 2000 to March 2012, they were the Clinical Science Director Europe at [AstraZeneca](/org/astrazeneca).

Javier Jimenez has a Master in Public Health from the National School of Public Health and is a Medical Doctor from the Universidad de Alcalá.

Javier Jimenez reports to Carolyn Starrett, CEO. Some of their coworkers include Lidia Bernik - VP, Head of Unstructured Data Processing Operations, Jaime Lopez - Chief Design & Marketing Officer, and Nirav Shah - VP, HC Revenue Cycle Management.

Javier Jimenez

Dr. Hugh Levaux is the Vice President and Head Growth Strategy for Clinical Research at Flatiron Health. Dr Levaux focuses on technologies, processes, competitors, and partners that will allow Flatiron to make generational leaps in interventional and observational clinical research. Dr. Levaux has over 20 years of dedicated experience in clinical trial design and operations, as well as clinical web-based technologies.

Prior to joining Flatiron, Dr. Levaux has held the roles of Founder and CEO of Protocol First (now a part of Flatiron), SVP at United BioSource Corporation (UBC), VP of Product Strategy at Medidata Solutions, CEO of Ninaza, a web-based EDC provider, and SVP at Quintiles (currently known as IQVIA). He has developed and commercialized multiple eClinical technologies in EDC, IVR/RTSM, ePRO/eCOA and trial-related technologies.

Dr. Levaux graduated from the Université libre de Bruxelles, Johns Hopkins School of Advanced International Studies, and he holds a PhD in Policy Analysis from Pardee RAND Graduate School. He is an ultrarunner and has completed several 100-mile events.

Hugh Levaux

Carla leads partnerships, mergers and acquisitions across functions and business units.

Carla joined Flatiron in 2022 from her previous role as Chief Business Development Officer at Paige, a pioneer of AI in Pathology. In this position, she led partnerships across verticals in addition to marketing and product strategy, her role encompassed ecosystem development, evidence generation and market strategy.

Over her current and previous roles, including Partnerships Lead of Healthcare AI at NVIDIA and Head of Corporate Development and Strategy at Arterys, Carla successfully crafted partnerships at the intersection of AI and healthcare, bringing together technologists, clinicians and product experts to build, study and launch AI-based products in the space.

Carla graduated from the Stanford Graduate School of Business with her masters in business administration and received her bachelors of science in engineering from both Massachusetts Institute of Technology and Stanford University.

Carla Leibowitz

Cal is the Head of Strategic Finance, the team responsible for the forecasting, management reporting and financial analysis that informs short-term tactical and long-term strategic decision making across the company. He has over 18 years of experience in finance, accounting and data analysis and is driven by building small, high performing teams that partner with business leaders to deliver insight and structure solutions that drive value and manage risk.

Prior to joining Flatiron in 2019, Cal led the Strategic Finance & Analytics team at Zendesk, having transitioned from the energy industry to technology via the Finance & Strategy team at Salesforce. 

Cal received an MBA from the Jones Graduate School of Business at Rice University, a Bachelor of Science in Business from Loughborough University, UK, and is a Chartered Global Management Accountant. 



Cal Brouilette

Shane Woods is the Chief Commercial Officer at [Flatiron Health](/org/flatiron-health). Shane was previously a Principal at Insight Strategy Advisors, where they consulted on life science and strategy issues for February 2010 to February 2015.

Shane Woods studied biochemistry at [Queen's University](/org/queens-university), where they earned a B.Sc. Honours. Shane then went on to study genetics at the [University of Cambridge](/org/university-of-cambridge), where they earned a Ph.D. After that, they became a Research Fellow in cancer biology at Harvard Medical School.

Shane Woods reports to Carolyn Starrett, CEO. Some direct reports include Sam Schmitz - Sales Director, Emily Guerin - Head of Communications. They work with James Hamrick - VP, Clinical Oncology, Nick Accomando - VP, Chief Compliance & Privacy Officer, and Meghna Samant - VP, Quantitative Sciences.

Shane Woods

Carolyn Starrett is currently the CEO at [Flatiron Health](/org/flatiron-health). Prior to that, they were the VP of Partnerships and Business Operations at Intent Media Inc., a startup company that uses predictive analytics to help ecommerce websites unlock new revenue streams. Carolyn was responsible for leading a team of 30+ people and grew the company's revenues from almost nothing to more than $100M in just three years. Carolyn has also worked as a Principal/Project Leader/Consultant at the Boston Consulting Group and as a Senior/Product Manager at Juniper Networks, Inc.

Carolyn Starrett received their MBA from Northwestern University - Kellogg School of Management, where they focused on strategy, finance, and entrepreneurship. Carolyn also participated in an MBA exchange program at [London Business School](/org/london-business-school). Carolyn earned their B.A. in business economics and English literature from Brown University. Carolyn also attended The Taft School.

Stephanie Reisinger - SVP & General Manager, Real-World Evidence, Ken Carson - Senior Medical Director, and Nina Chavez - VP, Value-Based Care, Practice Solutions & Transformation report to Carolyn Starrett.

Carolyn Starrett

Lesley Plotkin is the Director of Research Marketing at [Flatiron Health](/org/flatiron-health). Lesley has over fifteen years of experience in scientific publication, having led the scientific publication division at Phase Five Communications for nine years. There, they managed top ten pharmaceutical accounts across therapeutic areas, with an emphasis on oncology.

Lesley is an expert in developing communication strategies that are within budgetary and regulatory constraints. Lesley has cultivated relationships with key opinion leaders and community physicians serving as authors, advisory board members and/or investigators in clinical trials. These relationships have been integral in their ability to develop successful marketing campaigns.

In their current role at [Flatiron Health](/org/flatiron-health), Lesley is responsible for developing and executing marketing research strategies that support the [Flatiron Health](/org/flatiron-health) product suite. Lesley works closely with the product, sales, and marketing teams to ensure that the research marketing team is delivering insights that will help drive business decisions.

Lesley Plotkin graduated from [Colgate University](/org/colgate-university) with a B.A. in Biology and then went on to earn their M.A. in Psychology from [New York University](/org/nyu).

Lesley Plotkin

Lynn Howie serves as a medical director at Flatiron Health. She focuses on client solutions, including development of data sets and services to provide real world evidence to drive decision making by life science partners.  

Lynn’s research has focused on breast cancer therapies, developmental therapeutics, and regulatory policy and she has been published in multiple major peer-reviewed journals and has presented at national meetings.

Prior to Flatiron, Lynn was a community oncologist in western North Carolina where she cared for patients with cancer and blood disorders.  She served as a Medical Reviewer at the FDA in the Office of Hematology and Oncology Products from 2016 to 2019. Lynn is board certified in Medical Oncology, Hematology, and Internal Medicine. She received her MD with Distinction from the University of North Carolina at Chapel Hill, completed her internal medicine residency at The Johns Hopkins Hospital in Baltimore, MD and her fellowship in Hematology and Medical Oncology at Duke University in Durham, NC.



Lynn Howie

Julia leads the teams responsible for the experience of our network of oncology practices, and the operations and marketing behind the Flatiron HC™ platform.

Since joining Flatiron in 2015, Julia has built customer experience into a market differentiator, scaling high performing and customer-centric teams.

Previously, Julia worked in healthcare technology and consulting roles at ZocDoc, Bain & Co., Prophet, and Katzenbach.

Julia received a bachelor of arts in social studies and an MBA from [Harvard University](/org/harvard).



Julia Morton

Melissa leads the team that handles all Flatiron financial operations, from strategic initiatives such as M&A and international expansion, to accounting processes such as invoicing, collections, treasury, vendor payables, and procurement. She also oversees monthly financial close/reporting, technical accounting, financial systems, and adherence with compliance programs. 

Melissa joined Flatiron in 2017 with more than 15 years of financial accounting experience. As a vice president at Everyday Health, she guided the digital media company through an IPO, Sarbanes-Oxley Section-404 adoption, multiple acquisitions, and its sale and integration into J2 Global. Previously, she was a senior manager in Ernst & Young’s Assurance & Advisory practice. 

Melissa received a bachelor’s in accounting and graduated summa cum laude from [Binghamton University](/org/binghamton-university).

Melissa Lanzaro

Christine is responsible for building scalable decision-analytic solutions for Flatiron internally and for Flatiron customers, prototyping new products based on customer needs, and providing visibility into the patient journey through machine learning and analytics. 

Christine joined Flatiron in 2019 from [Spotify](/org/spotify), where she led the data solutions team to build scalable analytic solutions and develop predictive algorithms with a strong focus on improving and personalizing the customer experience. She previously held leadership roles in data science, engineering, and operations at [The New York Times](/org/new-york-times), Apple, and McKinsey. 

Christine received a bachelor of business administration in finance from [National Taiwan University](/org/national-taiwan-university) and a master’s in early childhood education and MBA from Stanford. 

She loves dancing and traveling and has been to 54 countries across five continents.



Christine Hung

Irene Nunes is head of regulatory affairs at Flatiron, where she leads a team of strategy and policy professionals who focus on advancing real-world data for regulatory decision-making by working with life science partners and global health authorities. In addition, she oversees Flatiron’s collaborations with health authorities and its leading roles in trade and health policy organizations to bring forward evidence-based scientific and policy solutions that enable real-world evidence for oncology research. 

Prior to joining Flatiron, Irene was head of regulatory affairs and pharmacovigilance at [TG Therapeutics](/org/tg-therapeutics), and developed and led regulatory teams at [Daiichi Sankyo](/org/daiichi-sankyo) and [Merck](/org/merck). Before entering the pharmaceutical industry, Irene was an NIH-funded neuroscientist at [Columbia University](/org/columbia-university). 

She received her OD at SUNY College of Optometry and PhD in cell and molecular biology at New York University School of Medicine.



Irene Nunes

Alex leads a team that builds on Flatiron’s established leadership in real-world evidence with new technologies and services to better integrate research into everyday clinical care. Flatiron Clinical Research helps sponsors and research sites design better studies, broaden access to and representativeness of clinical trials, accelerate timelines, and reduce the operational burden usually associated with clinical research.

Alex joined Flatiron in 2016 with a decade of experience working with oncology-focused pharmaceutical and biotech companies to address a wide range of strategic and operational challenges. 

Alex received a bachelor of science in biological engineering and a master of engineering in biomedical engineering from [Cornell University](/org/cornell-university).

Alex Deyle

Allison Blake

Anthony Lozano

Aaron Cohen is a medical oncologist who serves as medical director at [Flatiron Health](/org/flatiron-health), where he focuses on conducting health outcomes research. He specializes in real-world evidence generation.

Aaron’s research has focused on patient and physician decision making and conjoint analysis, with the aim of better incorporating health preference information into medical research.

Prior to Flatiron, Aaron received his medical degree from the [University of Pennsylvania](/org/university-of-pennsylvania) and trained in internal medicine at the Hospital of the [University of Pennsylvania](/org/university-of-pennsylvania). He then completed his oncology and hematology fellowship at the [University of Pennsylvania](/org/university-of-pennsylvania), where he served as chief fellow and also received his MSCE with a concentration in patient-centered outcomes research.



Aaron Cohen

Kathleen serves as general counsel at [Flatiron Health](/org/flatiron-health) where she is responsible for the legal, privacy and compliance functions.

Prior to joining Flatiron, Kathleen was associate general counsel at [Genentech](/org/genentech) in the corporate law and healthcare law groups, where she served as a critical thought partner and strategic advisor on leadership teams and to clients across the organization, including research and development, commercial, medical affairs, and public policy. Previous to [Genentech](/org/genentech), Kathleen practiced in Philadelphia as a healthcare attorney at [AstraZeneca](/org/astrazeneca) and before that, as an associate in the business and finance group at the law firm Morgan, Lewis & Bockius.

Outside work, Kathleen has been dedicated to community service, focused primarily on youth well-being. She has served as chair of the board for Youth Community Service and on the leadership team for Project Safety Net in Palo Alto.



Kathleen Blanchard

Neal J. Meropol, MD is a medical oncologist, clinical investigator and outcomes researcher who serves as Vice President of Research Oncology at [Flatiron Health](/org/flatiron-health). In this role, he provides scientific and clinical leadership in leveraging Flatiron’s technology platforms to close the gap between research and clinical care. 

Dr. Meropol’s research contributions span drug development and health services research, including evaluation of new agents, predictors of response and outcome, development of tools to overcome barriers to clinical trial participation, and assessment of the economic impact of care. 

He is an appointed member of the NCI Director’s Clinical Trials and Translational Research Advisory Committee (CTAC), and previously served as Chair of the National Cancer Institute Gastrointestinal Cancer Steering Committee. Dr. Meropol completed a four-year term as an elected member of the American Society of Clinical Oncology (ASCO) Board of Directors, and currently serves on the ASCO Research Committee. He is a member of the National Academies of Science, Engineering and Medicine National Cancer Policy Forum. A committed educator, Dr. Meropol served as faculty and chair of the AACR/ASCO Methods in Cancer Clinical Research Vail Workshop, and ASCO Leadership Development Program. He has authored more than 300 manuscripts, book chapters, and editorials related to cancer prevention, treatment, decision making and health economics.

Prior to joining Flatiron, he served as Professor and Chief of the Division of Hematology and Oncology at University Hospitals Cleveland Medical Center and [Case Western Reserve University](/org/case-western-reserve-university), and Associate Director for Clinical Research at the Case Comprehensive Cancer Center.

Dr. Meropol holds a Bachelor’s degree from [Princeton University](/org/princeton) in Philosophy, and MD from [Vanderbilt University](/org/vanderbilt-university). He was a resident in Internal Medicine at [Case Western Reserve University](/org/case-western-reserve-university), and completed Hematology and Medical Oncology fellowships at the University of Pennsylvania. He spent a sabbatical at the Leonard Davis Institute of Health Economics at the Wharton School of the University of Pennsylvania.



Neal Meropol

James Hamrick leads a team of doctors, nurses, and informatics specialists who inform the development and applications of the Flatiron HC™ products and services relied upon by front-line clinicians in hundreds of cancer clinics across the United States. 

James also maintains a clinical practice part-time at Kaiser Permanente of Georgia in Atlanta, where he previously served as chief of medical oncology and hematology.

James joined Flatiron from Kaiser Permanente of Georgia in 2016 and previously practiced oncology and hematology at [Georgia Cancer Specialists](/org/georgia-cancer-specialists). He is on the board of the Georgia Center for Oncology Research and Education, and previously served on the Kaiser Permanente National Inter-Regional Cancer Leadership Council and the KP National Cancer Chiefs Council.

James received his MD and an MPH in epidemiology from the [University of North Carolina at Chapel Hill](/org/university-of-north-carolina-at-chapel-hill). He completed his residency and hematology/oncology fellowship at the [University of California San Francisco](/org/university-of-california-san-francisco).

James is board-certified in internal medicine, medical oncology, and hematology.

James Hamrick

Nat Turner is the Co-Founder of [Flatiron Health](/org/flatiron-health).

Nat Turner was previously co-founder and CEO of [Flatiron Health](/org/flatiron-health), where he oversaw all initiatives across provider solutions, clinical oncology, business development, sales operations, legal, and other corporate functions.

Before co-founding [Flatiron Health](/org/flatiron-health), Nat was co-founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry’s first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010.

Prior to Invite Media, Nat started numerous internet companies and also worked at Say Media and [First Round Capital](/org/first-round-capital). An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, [Clover Health](/org/clover-health), Color Genomics, Doctor Evidence, [Gravie](/org/gravie), [Notable Labs](/org/notablelabs), Oscar and [Quartet Health](/org/quartet-health).

Nat earned a Bachelor of Science degree cum laude in economics with concentrations in entrepreneurship and marketing from the Wharton School at the [University of Pennsylvania](/org/university-of-pennsylvania).

Nat Turner

Erlene Seymour is a malignant hematologist who serves as a medical director at [Flatiron Health](/org/flatiron-health), where she focuses on conducting outcomes research and curating education around real-world data.

Prior to joining Flatiron in 2021, Erlene served as an assistant professor at Barbara Ann Karmanos Cancer Institute/Wayne State University, where she was a clinical trial investigator focused on chronic lymphocytic leukemia and lymphoma. Her health services research focused on the effects on patients of the financial burden of cancer treatments and on value-based initiatives aimed at decreasing out-of-pocket costs. 

Erlene’s work has been published in major peer-reviewed journals and she serves on an American Society of Hematology subcommittee.

Erlene received a bachelor of science in cellular and molecular biology from the University of Michigan and an MD from [Wayne State University](/org/wayne-state-university) School of Medicine. She completed her internal medicine residency, and hematology and oncology fellowship, at the University of Michigan.

Erlene Seymour

Nick is responsible for leading the compliance and privacy teams who are responsible for ensuring that Flatiron Health maintains the highest level of integrity and ethical standards by conducting its business activities in accordance with applicable laws and regulations, while also advocating for the safe use and handling of patient information.
 
Nick joined Flatiron with fifteen years of legal, compliance, and privacy experience within the provider, tech, data, and life sciences spaces. Prior to joining Flatiron in December 2021, he held global roles at GSK, IQVIA, and IBM Watson Health, where his work was at the intersection of data, technology, AI, and privacy with a strong focus on de-identification methodologies and data transformation technologies.
 
Nick received a B.A. in Theology from Boston College and he received his J.D. from Loyola College of Law, New Orleans. He is licensed as an attorney in the state of Massachusetts and is a certified information privacy professional.

Nick Accomando

Trevor Royce is a radiation oncologist and health outcomes/policy researcher who serves as medical director at [Flatiron Health](/org/flatiron-health), where he focuses on conducting outcomes research. 

Trevor received his undergraduate degree in biomedical engineering from the [University of Virginia](/org/university-of-virginia) and an MD from the [University of North Carolina](/org/university-of-north-carolina). He completed a radiation oncology residency at the Harvard Radiation Oncology Program and earned an MPH from the Harvard School of Public Health.

Trevor Royce

Ken Carson

Rebecca Miksad

Emily Castellanos

Sarah is responsible for designing and leading the strategic roadmap for Flatiron’s enablement of financial success of our key partnership practices directly overseeing our revenue cycle operations, while working cross functionally with many Flatiron teams including (but not limited to) product and value-based care.

During her career, Sarah has acted as a recognized thought leader, building the foundation of her career focused in oncology practice financial success through leading payer partnerships and integrated operational collaboration to deliver a best in class oncology experience for the communities she served. She has a deep understanding of the evolving healthcare continuum and system awareness to drive transformational change through innovative payment models and efficient operational design that allows practices to treat their patients and be the leaders in their markets.

Sarah Cevallos

Jason leads the teams responsible for Flatiron’s cloud infrastructure, software development life cycle and data platforms, employee and office IT services, and sales and financial corporate applications.

Jason joined Flatiron in 2017 with 10 years of experience as an engineering leader and technologist. He previously was senior director of engineering at [Rackspace](/org/rackspace), providing technical strategy and guidance to the private cloud engineering and product teams. Prior to [Rackspace](/org/rackspace),  Jason worked at the U.S. Army Training and Doctrine Command in White Sands, NM where he helped build high-performing computer clusters and executed day-to-day network operations.

Jason received a bachelor of science in computer science from [New Mexico State University](/org/new-mexico-state-university). 

Jason Cannavale

Cat oversees the software engineering teams that build and deliver Flatiron’s real-world evidence (RWE) products and services, including our Enhanced Datamart, Spotlight, and prospective evidence products. She has been responsible for the RWE business line since its inception in 2014. In addition, for the past four years, Cat has been a key recruiting partner, more than doubling the software engineering team.

Prior to joining Flatiron in 2014, Cat was an early engineer at data-focused startups Mortar Data and Optum Humedica. She also acted in films including “Forever Mind.”

Cat has bachelors of science in mathematics and computer science and a master of engineering in computer science from the Massachusetts Institute of Technology.

Catherine Miller

Quincy Weatherspoon is the Head of Sales and Marketing for Flatiron HC. He has over 12 years of marketing and commercial operations experience and values building customer relationships.

In his role at Flatiron Health, Quincy uses his global leadership background to oversee sales and marketing the Flatiron HC platform to community oncology and health systems customers at Flatiron Health. 

Prior to joining Flatiron in 2021, Quincy served as the Vice President of Marketing for Revenue Cycle Management at Change Healthcare. Quincy also spent 12 years with Avanos Medical and served in global commercial leadership roles across multiple business units. 

He holds a Bachelor’s in Business Administration from Ohio Northern University with a focus on Finance and Marketing and obtained an MBA from the University of Cincinnati in Finance.

Quincy Weatherspoon

Sam Schmitz

Barbara Rosen is Director of Corporate Communications at Flatiron Health, a position she has held since March of 2020.

Prior to Flatiron, Barbara was an independent communications consultant.

Barbara Rosen

Adrian Dana

Stephanie leads the Real-World Evidence business unit, setting the strategy to drive long term growth and to accelerate Flatiron’s  leadership in the way real-world oncology data is collected, combined and analyzed.

Steph joined Flatiron in 2022, with 20 years of experience leading businesses at the intersection of real-world patient data, technology, and analytics within the life sciences industry.  Prior to Flatiron, she served as the General Manager of Life Sciences Data and Analytics at Veradigm, an analytics subsidiary of Allscripts. 

Steph earned her bachelor’s degree at Widener University and is a candidate for her master’s in business administration at the Smeal College of Business at Penn State University.

Stephanie Reisinger

Nathan leads teams that develop strategic partnerships and projects to accelerate Flatiron’s growth and enhance product offerings, and he spearheads the company’s expansion beyond the United States. 

Nathan joined Flatiron in 2020 with 20 years of pharmaceutical experience in business development and commercial leadership in the United States, Canada, and China.

He previously was global head of healthcare ecosystems at Roche Pharmaceuticals, establishing personalized health care collaborations in 10+ countries, and also served as director of data and digital partnering. 

Nathan received a bachelor of arts in economics, with minors in english literature and psychology, from [DePauw University](/org/depauw-university) and an MBA from [Stanford University](/org/stanford).

Nathan Hubbard

Nina Chavez is Vice President of Flatiron Health’s Value-Based Care and Practice Solution & Transformation teams. She is a subject matter expert in value-based care and clinical practice transformation. 

Nina focuses on customer impact, demonstrated in her creation of Flatiron’s Strategic Advisory Committee (SAC). The SAC gathers feedback from strategic business leaders within the Flatiron HC network on early-stage initiatives, products and services. 

Nina joined Flatiron in 2020 with 16 years of practice experience at the New Mexico Cancer Center (NMCC). In her previous role as Chief Operating Officer at NMCC, she served on the boards of the Association of Community Cancer Centers and the Coalition of Hematology and Oncology Practices. Additionally, she is a fellow with the American College of Medical Practice Executives. 

Nina received a Bachelor of Science and an MBA in Business Administration and Management from the University of Phoenix. 

Nina loves to share her passion for both her home state of New Mexico and her state of origin, Hawaii.

Nina Chavez

Donna Edgerton leads the Integrated Quality Management team to develop and execute strategy for Quality Assurance programs across Flatiron’s software and research products and services. 

Her 30+ years of experience includes research operations and health-outcomes research roles in academic settings; and clinical operations, training, compliance and quality assurance leadership roles in large and small biopharmaceutical development organizations.  

Donna is passionate about utilizing quality by design and improving patients’ healthcare outcomes and quality of life. 

Donna holds a Bachelor’s degree in Nursing from the University of Washington. 

Donna enjoys walking on the beach near her home and having dinner with family and friends in her spare time.

Donna Edgerton

Meghna Samant is the Vice President of Quantitative Sciences at Flatiron Health. With 15 years of experience, she leads the strategic development of high-quality, real-world datasets and real-world endpoints.

 In her role at Flatiron Health, Meghna uses her leadership background in global development to oversee teams of health economists, outcome researchers, biostatisticians, epidemiologists and data scientists, to optimize data usability and availability – which contributes significantly to the healthcare ecosystem. 

Prior to joining Flatiron Health in 2018, Meghna was a senior leader at Roche/Genentech, where she worked across the solid tumor and hematology portfolio.

She holds a Bachelor’s degree in Mathematics and Computer Science from the College of Saint Elizabeth, New Jersey and a Ph.D. in Biostatistics from the University of California, Los Angeles. 

Outside work, Meghna is an avid sports and travel enthusiast and loves spending time exploring the outdoors with family and friends.

Meghna Samant

Jaime Lopez is the Chief Design & Marketing Officer at [Flatiron Health](/org/flatiron-health). She has over 15 years of startup product, design and marketing experience with a passion for creative problem solving and building and mentoring teams. 

In her role at [Flatiron Health](/org/flatiron-health), Jaime uses her background to create and deliver high-quality experiences to oversee the company’s entire marketing and design suite. 

Prior to joining [Flatiron Health](/org/flatiron-health) in 2016, Jaime led the design team at Opower, a startup working to address climate change, and worked for clients such as The Pan American Health Organization, Nestle, HP, Product (Red) and Neil Diamond. 

She holds a Bachelor’s degree from the [Art Center College of Design](/org/art-center-college-of-design) with a focus on Design for Social Impact. Her work has been recognized by Communication Arts Magazine, HOW International Design Annual Awards, Art Directors Club, Print Magazine and The Fast Company Innovation Awards.

Jaime Lopez

Jacqueline leads the strategy and development of Flatiron products and solutions for oncology research. 

She joined Flatiron in 2021 with 20+ years of experience in pharmaceuticals, diagnostics, and consulting in the United States, Europe, and China. Previously Jacqueline was a vice president and global head of personalized healthcare data science at Roche/Genentech, leading a team responsible for real-world data strategy and execution and developing personalized healthcare solutions. 

Jacqueline received a PhD in biostatistics from the University of California, Los Angeles.

Jacqueline is passionate about the novel use of data and technology in healthcare to benefit patients.



Jacqueline Law

Josh Defrain

Lidia leads the team responsible for the end-to-end operation that enables Flatiron to convert unstructured data into structured data. This encompasses 1,800+ abstractors who extract key data from electronic health records as well as 120+ full-time employees responsible for developing new abstraction approaches, managing operations, monitoring and controlling data quality, and helping maintain and improve our RWE datasets. 

Lidia joined Flatiron in 2016 with over 10 years of experience in the healthcare and non-profit sectors. As a director in Weill Cornell Medicine’s Department of Healthcare Policy and Research, she managed the New York City Clinical Data Research Network. She also built and oversaw the project management department within the business and strategic planning office at Mount Sinai Health System.

Lidia received a bachelor of science in human service studies from [Cornell University](/org/cornell-university), a master of health science from the Johns Hopkins Bloomberg School of Public Health, and an MBA in healthcare administration from the Zicklin School of Business at [Baruch College](/org/baruch).

Flatiron Health

Org chart

Teams

Leadership Team

CEO and Executive Team

Board of Directors

Founding Team

Discover similar companies